Independent
Tenure on this board
6.4 yrs
9 nominees · 2 ballot items.
Proposal 1: Amend the Certificate of Incorporation to increase total authorized shares (capital stock from 170,000,000 to 320,000,000 and common stock from 150,000,000 to 300,000,000); Proposal 2: Approve adjournment of the Special Meeting to permit further solicitation of proxies if votes are insufficient to approve Proposal 1.
Approve an amendment to the Company’s Certificate of Incorporation to increase total authorized shares from 170,000,000 to 320,000,000 and authorized common stock from 150,000,000 to 300,000,000 to provide flexibility for financings, equity compensation, collaborations, acquisitions and other corporate purposes.
Proposal 1 requests shareholder approval to amend the Company’s Certificate of Incorporation to increase authorized shares of capital stock from 170 million to 320 million and authorized common stock from 150 million to 300 million. Management is seeking this approval to provide the Company with flexibility to issue shares for potential financings (including the Company’s at-the-market program under its Open Market Sales Agreement and its universal shelf registration), partnerships, collaborations, strategic investments, acquisitions, and equity compensation without the delay and expense of a separate stockholder vote. The proposal is explicitly tied to a requirement under the Company’s July 14, 2026 Securities Purchase Agreement, making it a transactional necessity in addition to a strategic option. The proxy statement discloses currently outstanding dilutive instruments (warrants and options) and shares reserved under equity plans, indicating imminent potential dilution if those instruments are exercised; the proposed increase would add a sizeable reserve of common shares available for such uses. While the board states the amendment is not intended as an anti-takeover device, the increase in authorized shares could have the incidental anti-takeover effect of making hostile acquisitions more difficult. The company notes potential adverse effects for existing holders including dilution of earnings per share, voting power, and stockholders’ equity, and warns that future sales or perceived sales could depress market price. The Board reserves discretion to abandon the amendment prior to filing even if authorized by stockholders, which preserves managerial flexibility but reduces shareholder control over timing and implementation. Given the company’s financing history, the open ATM sales agreement, outstanding warrants and option pools, the amendment would materially expand the company’s ability to raise capital and grant equity, making it strategically significant for near-term financing options. The Board recommends a FOR vote, arguing that the increased authorized shares are in the best interests of the Company and its stockholders because they facilitate capitalization and strategic transactions that management may pursue.
Authorize the proxies to adjourn the Special Meeting to a later date or dates, if necessary, to permit further solicitation of proxies in the event there are insufficient votes to adopt Proposal 1.
Proposal 2 asks shareholders to empower the Board’s proxies to adjourn the Special Meeting if there are insufficient votes to approve Proposal 1, providing the Board with the ability to continue soliciting proxies or reassess strategy without concluding the meeting with a failed vote on the amendment. Management is seeking shareholder approval to ensure it can obtain additional time to solicit votes, potentially reverse unfavorable indications, and avoid a premature defeat that could limit near-term financing and strategic options tied to the authorized shares increase. The proposal would allow the Company to reconvene without further notice other than an announcement at the meeting and to retain previously submitted proxies unless revoked, which preserves solicitation efficiency but could delay finality for shareholders. Use of adjournment could also permit targeted outreach to holders of outstanding warrants, option holders, or large shareholders to address concerns or negotiate support. While adjournments are common procedural tools, they can be used to change the momentum of a vote; shareholders should weigh the benefit of additional solicitation time against the potential for managerial entrenchment or delaying shareholder resolution. The Board’s recommendation for a FOR vote is premised on facilitating approval of Proposal 1, which the Board argues is in the company’s and stockholders’ best interests. Approval of Proposal 2 does not itself change corporate rights but is strictly procedural; its primary significance is to enable the implementation of Proposal 1 if more time is needed to secure votes.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Laurion Capital Management LP | 3.98% | 3,098,299 | $4M |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 3.72% | 2,895,592 | $4M |
| 3 | PFIZER INC | 3.10% | 2,411,575 | $3M |
| 4 | FRANKLIN RESOURCES INC | 1.55% | 1,205,803 | $2M |
| 5 | BLAIR WILLIAM CO/IL | 1.17% | 912,513 | $1M |
| 6 | BlackRock, Inc. | 0.89% | 693,862 | $902K |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 0.86% | 671,088 | $873K |
| 8 | UBS Group AG | 0.60% | 465,269 | $605K |
| 9 | VANGUARD FIDUCIARY TRUST CO | 0.53% | 410,602 | $534K |
| 10 | JANE STREET GROUP, LLC | 0.51% | 396,054 | $515K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.